Cullinan Associates’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.17M | Sell |
6,595
-1,950
| -23% | -$700K | 0.18% | 89 |
|
|
2025
Q4 | $3M | Buy |
8,545
+350
| +4% | +$128K | 0.2% | 86 |
|
|
2025
Q3 | $3.03M | Buy |
8,195
+50
| +0.6% | +$19.3K | 0.2% | 86 |
|
|
2025
Q2 | $3.22M | Buy |
8,145
+520
| +7% | +$195K | 0.21% | 84 |
|
|
2025
Q1 | $2.84M | Buy |
7,625
+1,700
| +29% | +$647K | 0.2% | 93 |
|
|
2024
Q4 | $2.13M | Sell |
5,925
-1,440
| -20% | -$534K | 0.14% | 105 |
|
|
2024
Q3 | $2.71M | Sell |
7,365
-366
| -5% | -$126K | 0.15% | 104 |
|
|
2024
Q2 | $2.63M | Buy |
7,731
+700
| +10% | +$237K | 0.15% | 104 |
|
|
2024
Q1 | $2.52M | Sell |
7,031
-12,715
| -64% | -$4.28M | 0.14% | 112 |
|
|
2023
Q4 | $5.91M | Sell |
19,746
-1,372
| -6% | -$385K | 0.33% | 68 |
|
|
2023
Q3 | $5.77M | Buy |
21,118
+850
| +4% | +$244K | 0.34% | 68 |
|
|
2023
Q2 | $6.18M | Sell |
20,268
-826
| -4% | -$239K | 0.34% | 72 |
|
|
2023
Q1 | $6.02M | Sell |
21,094
-57
| -0.3% | -$15.1K | 0.35% | 79 |
|
|
2022
Q4 | $5.17M | Sell |
21,151
-300
| -1% | -$68.1K | 0.29% | 79 |
|
|
2022
Q3 | $4.34M | Sell |
21,451
-860
| -4% | -$181K | 0.27% | 88 |
|
|
2022
Q2 | $4.44M | Sell |
22,311
-7,200
| -24% | -$1.69M | 0.27% | 85 |
|
|
2022
Q1 | $7.89M | Sell |
29,511
-386
| -1% | -$99.9K | 0.41% | 67 |
|
|
2021
Q4 | $8M | Sell |
29,897
-200
| -0.7% | -$52.5K | 0.41% | 69 |
|
|
2021
Q3 | $7.94M | Buy |
30,097
+355
| +1% | +$94.9K | 0.44% | 66 |
|
|
2021
Q2 | $7.72M | Sell |
29,742
-50
| -0.2% | -$12.8K | 0.43% | 70 |
|
|
2021
Q1 | $7.26M | Sell |
29,792
-230
| -0.8% | -$55.2K | 0.42% | 69 |
|
|
2020
Q4 | $7.36M | Buy |
30,022
+110
| +0.4% | +$24.9K | 0.44% | 64 |
|
|
2020
Q3 | $6.23M | Sell |
29,912
-7,995
| -21% | -$1.55M | 0.4% | 66 |
|
|
2020
Q2 | $6.83M | Buy |
37,907
+1,090
| +3% | +$201K | 0.48% | 52 |
|
|
2020
Q1 | $6.13M | Buy |
36,817
+2,195
| +6% | +$429K | 0.5% | 52 |
|
|
2019
Q4 | $7.27M | Buy |
34,622
+6,802
| +24% | +$1.41M | 0.49% | 56 |
|
|
2019
Q3 | $6.02M | Sell |
27,820
-2,025
| -7% | -$434K | 0.43% | 67 |
|
|
2019
Q2 | $6.14M | Sell |
29,845
-7,470
| -20% | -$1.43M | 0.45% | 62 |
|
|
2019
Q1 | $7.37M | Buy |
37,315
+8,547
| +30% | +$1.54M | 0.55% | 49 |
|
|
2018
Q4 | $4.51M | Buy |
28,768
+3,154
| +12% | +$528K | 0.37% | 67 |
|
|
2018
Q3 | $4.55M | Buy |
25,614
+7,190
| +39% | +$1.23M | 0.33% | 83 |
|
|
2018
Q2 | $3.11M | Buy |
+18,424
| New | +$3.1M | 0.24% | 98 |
|
|
2017
Q3 | – | Sell |
-1,900
| Closed | -$264K | – | 202 |
|
|
2017
Q2 | $264K | Hold |
1,900
| – | – | 0.02% | 185 |
|
|
2017
Q1 | $250K | Hold |
1,900
| – | – | 0.02% | 188 |
|
|
2016
Q4 | $228K | Hold |
1,900
| – | – | 0.02% | 188 |
|
|
2016
Q3 | $221K | Sell |
1,900
-3,225
| -63% | -$376K | 0.02% | 192 |
|
|
2016
Q2 | $614K | Hold |
5,125
| – | – | 0.05% | 150 |
|
|
2016
Q1 | $550K | Sell |
5,125
-1,300
| -20% | -$128K | 0.05% | 153 |
|
|
2015
Q4 | $597K | Sell |
6,425
-500
| -7% | -$47.9K | 0.05% | 156 |
|
|
2015
Q3 | $652K | Hold |
6,925
| – | – | 0.06% | 160 |
|
|
2015
Q2 | $662K | Buy |
6,925
+200
| +3% | +$19K | 0.05% | 164 |
|
|
2015
Q1 | $620K | Buy |
+6,725
| New | +$626K | 0.05% | 168 |
|
|
2014
Q3 | – | Sell |
-21,597
| Closed | -$1.4M | – | 95 |
|
|
2014
Q2 | $1.4M | Buy |
21,597
+10,397
| +93% | +$849K | 0.23% | 58 |
|
|
2014
Q1 | $912K | Sell |
11,200
-11,300
| -50% | -$899K | 0.1% | 77 |
|
|
2013
Q4 | $1.69M | Sell |
22,500
-20,168
| -47% | -$1.47M | 0.2% | 58 |
|
|
2013
Q3 | $2.88M | Sell |
42,668
-3,430
| -7% | -$237K | 0.39% | 40 |
|
|
2013
Q2 | $2.98M | Buy |
+46,098
| New | +$3.06M | 0.4% | 40 |
|
Other funds holding SYK
VCM
GT
VPM
Cullinan Associates's SYK Position: Q1 2026 in Review
Cullinan Associates reduced its Stryker (SYK) stake by 23% in Q1 2026, selling an estimated $700K and leaving 6,595 shares worth $2.17M. The position accounts for 0.18% of the portfolio, ranked #89.
Cullinan Associates first reported a position in SYK in Q2 2013 and has held it in 47 quarters since. The position peaked at $8M in Q4 2021. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.
- Cullinan Associates held 6,595 shares of Stryker worth $2.17M as of Q1 2026.
- Cullinan Associates sold 1,950 Stryker shares in Q1 2026, an estimated $700K.
- Stryker made up 0.18% of Cullinan Associates's portfolio in Q1 2026, its #89 holding.
- Cullinan Associates first reported a position in Stryker in Q2 2013 and has held it in 47 quarters since.
- Cullinan Associates's Stryker position peaked at $8M in Q4 2021.
- 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.
Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.